Table 1—

Characteristics of study patients enrolled in metformin and troglitazone treatment groups

MetforminTroglitazone
Age (years)56±256±2
Sex (male/female)11/19/1
Weight (kg)96.3±8.3110.4±5.4
BMI (kg/m2)31.6±2.736.3±2.2
Fasting plasma glucose (mg/dl)224±12192±10*
HbA1c (%)9.2±0.48.6±0.3
Fasting insulin (mU/l)36.6±5.740.6±7.1
GDR (mg · kg−1 · min−1)6.15±0.495.21±0.71
  • Data are means ±SEM or n.

  • *

    * Significant at P=0.05.